WAVE Life Sciences Ltd.
WVE
$6.73
-$0.06-0.88%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -97.01M | -142.52M | -73.49M | -61.67M | -57.51M |
| Total Depreciation and Amortization | 8.66M | 8.69M | 8.80M | 8.95M | 9.21M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.14M | 12.25M | 11.00M | 9.93M | 9.80M |
| Change in Net Operating Assets | -75.82M | -19.04M | -74.91M | -95.59M | 19.08M |
| Cash from Operations | -151.03M | -140.62M | -128.60M | -138.39M | -19.43M |
| Capital Expenditure | -938.00K | -1.21M | -1.02M | -1.04M | -1.12M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -938.00K | -1.21M | -1.02M | -1.04M | -1.12M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 239.81M | 298.77M | 110.80M | 111.99M | 132.53M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 14.08M | 14.10M | -- | -- | -- |
| Cash from Financing | 253.89M | 312.87M | 110.80M | 111.99M | 132.53M |
| Foreign Exchange rate Adjustments | -138.00K | 23.00K | -129.00K | -148.00K | -95.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.79M | 171.07M | -18.95M | -27.59M | 111.89M |